Drug Database
TE

teriparatide (Xinfutai Pro)

✓ Approved

Shenzhen Salubris Pharmaceuticals Co., Ltd. · PTH1R · 重组蛋白

什么是 teriparatide?

teriparatide 是一种重组蛋白,由Shenzhen Salubris Pharmaceuticals Co., Ltd.研发。该药已获批,用于治疗相关适应症,给药途径:Injectable (Others)。

药物档案

商品名Xinfutai Pro
公司Shenzhen Salubris Pharmaceuticals Co., Ltd.
药物类别重组蛋白
分子靶点PTH1R
给药途径Injectable (Others)
状态Approved

作用机制

分子靶点

teriparatide 作用于 1 个分子靶点:

PTH1Rparathyroid hormone 1 receptor (PTHR, EKNS)
需要更深入的分析?Noah AI 可解释复杂机制并与同类药物比较。

治疗适应症

teriparatide 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Musculoskeletal and connective tissue disordersOsteoporosis✓ Approved

相关研究文献

PubMedBMC chemistry2026-11-19

Extractive ion-pair spectrophotometric methods utilizing bromocresol green to estimate chlorpheniramine maleate in pharmaceutical formulations.

Murshed Fatima A FA, Al-Mawri Siham H A SHA, Abdulrahman Sameer A M SAM

Two accurate, sensitive, and cost-effective spectrophotometric methods were developed and validated for the quantitative determination of Chlorpheniramine Maleate (CPM). Method A is based on the formation of a yellow ion-pair complex between CPM and bromocresol green (BCG) in an acidic medium. The resulting complex is extracted into dichloromethane, and its absorbance is measured at 414 nm. Method B involves the dissociation of the yellow-colored CPM-BCG ion-pair complex in a basic medium, leading to the development of a blue color that gives a maximum absorbance at 618 nm. Beer's law was found to be valid within the concentration ranges of 1.00-25.0 µg/mL for method A and 0.20-9.00 µg/mL for method B. The molar absorptivities were determined and found to be 1.76 × 104 and 4.47 × 104 L/(mol.cm) for methods A and B, respectively, with Sandell sensitivity values of 0.0222 and 0.0087 µg/cm². Detection and quantification limits were determined and found to be 0.2049 and 0.6210 µg/mL for method A, and 0.0199 and 0.0603 µg/mL for method B, respectively. The linearity was excellent with correlation coefficients of 0.9995 and 0.9997 for methods A and B. The developed methods were successfully employed to determine CPM in both its pure form and commercial pharmaceutical formulations. The methods were highly precise, with relative standard deviations between 0.24% and 1.85%, and highly accurate, with recovery percentages ranging from 98.14% to 100.8% when applied to pharmaceutical formulations. Statistical comparison with the official USP HPLC method showed no significant differences in accuracy or precision, making the developed methods ideal for routine quality control in resource-limited settings.

PMID 43053190
阅读全文 →
PubMedJournal of the American Chemical Society2026-11-19

Coexisting Liquid-, Glassy-, and Crystal-like Phonons in a Crystalline Solid.

Feng Yuanwen Y, Xie Lin L, Ohira-Kawamura Seiko S, Qi Ji J et al.

As main states of matter, crystal, glass, and liquid manifest themselves in distinct transverse collective atomic vibrations. In contrast to crystals where transverse phonons are well-defined throughout Brillouin zones, glasses and liquids process such motions in long and/or short wavelength limits, respectively. Considerable efforts have been made to experimentally probe transverse phonon behavior in these highly anharmonic and disordered materials in pursuit of a universal framework for thermal transport. In this work, inelastic neutron scattering on AgCrSe2 single crystals reveals liquid-, glassy-, and crystal-like phonon features along different crystallographic directions. In particular, the liquid-like behavior is attributed to the significant softening and scattering arising from the nesting effect and dynamical atomic disorder while the glassy-like behavior is due to the selective disorder effect. Our findings challenge conventional boundaries between states of matter at the level of atomic dynamics and establish a materials platform for unifying the thermal transport theories across different states.

PMID 43053416
阅读全文 →
PubMedLuminescence : the journal of biological and chemical luminescence2026-11-19

Molecularly Engineered Triphenylamine-Based Schiff Base Co-Sensitizers for DSSCs With Liquid and PAN/PEG Polymer Gel Electrolytes and for 12% Efficient Tandem Devices With Liquid Electrolyte.

Abumelha Hana M HM, Osra Khalid A KA, Alshahrani Maryam M, Alshammari Nadiyah M NM et al.

Two novel triphenylamine-based donor-π-acceptor Schiff base sensitizers, TBY-1 and TBC-1, were systematically designed, synthesized, and assessed as co-sensitizers with N719 for the enhancement photovoltaic performance. The two dyes were constructed to probe the effect of acceptor engineering on light harvesting, charge-transfer characteristics, and device efficiency. Spectroscopic analysis showed that TBC-1 exhibited broader and more red-shifted visible absorption than TBY-1, indicating stronger intramolecular charge transfer and improved solar-spectrum utilization. Density functional theory and complementary electronic analyses further confirmed that TBC-1 possesses enhanced electron delocalization, stronger donor-acceptor separation, and more favorable interfacial electronic characteristics. When co-sensitized with N719, both dyes significantly improved the photovoltaic performance relative to N719 alone in both liquid and PAN/PEG polymer gel electrolytes. The best liquid-electrolyte device, based on TBC-1 + N719, achieved a power conversion efficiency of 11.98% with VOC = 0.740 V, JSC = 23.50 mA cm-2, and FF = 68.89%, while the corresponding quasi-solid-state device retained a high efficiency of 10.45%. Upon using parallel tandem DSSC with the N719 (top)/TBC-1 (bottom) delivering the highest efficiency of 12.34% under AM 1.5G illumination. Electrochemical impedance and Bode analyses revealed that the improved performance originated from enhanced light harvesting, suppressed interfacial recombination, and prolonged electron lifetime, while long-term stability measurements demonstrated excellent operational durability over 300 h of continuous illumination. These findings highlight acceptor engineering and tandem sensitization as effective strategies for developing efficient and stable next-generation DSSCs.

PMID 43053595
阅读全文 →
PubMedRespiratory research2026-11-19

Association between sodium-glucose cotransporter 2 inhibitors and the risk of chronic lower respiratory disease in type 2 diabetes mellitus: findings from two target trial emulations.

Li Yuhao Y, Lv Yiqiao Y, Dai Yongqi Y, Zeng Huatang H et al.

Research on the association between sodium‑glucose cotransporter 2 inhibitors (SGLT-2i) and chronic lower respiratory diseases (CLRDs) in patients with type 2 diabetes (T2DM) remains limited. This study aimed to investigate this association and examine the potential modifying effects such as age, sex, and diabetes severity. Using the Shenzhen Public Health Data Platform, we conducted two independent target trial emulations with a new‑user active comparator design, comparing SGLT‑2i with glucagon‑like peptide‑1 receptor agonists (GLP-1RA) and dipeptidyl peptidase‑4 inhibitors (DPP‑4i), respectively. The primary outcome was incident CLRD; secondary outcomes included five subtypes-bronchitis, bronchiectasis, asthma, chronic obstructive pulmonary disease, and emphysema. Overlap-weighted Cox models estimated hazard ratios (HRs) and 95% confidence intervals (CIs). During a median follow-up of 1.76 years, 349 (7.95%) and 397 (9.04%) new CLRD cases occurred in SGLT-2i and GLP-1RA users, respectively. Compared with GLP-1RA, SGLT-2i use was associated with a lower CLRD incidence (HR 0.87, 95% CI 0.79-0.96), primarily driven by reduced risk of bronchitis (HR: 0.89; 95% CI: 0.79-1.00) and asthma (HR: 0.77; 95% CI: 0.58-1.01); no significant associations were found for other subtypes. Compared with DPP-4i, SGLT-2i use showed a trend toward lower CLRD risk (HR: 0.95; 95% CI: 0.91-0.99), with significant reductions for bronchitis (HR: 0.95; 95% CI: 0.91-1.00), bronchiectasis (HR: 0.86; 95% CI: 0.75-1.00), and asthma (HR: 0.87; 95% CI: 0.77-0.98). Subgroup analyses indicated significant interactions for bronchiectasis by sex (P interaction = 0.001). Compared with GLP-1 RA, SGLT-2i were associated with a significantly lower risk of CLRDs, driven predominantly by bronchitis; versus DPP-4i, the risk reduction was primarily observed for bronchitis, bronchiectasis, and asthma. The protective association between SGLT-2i use and bronchiectasis was more pronounced in females than in males relative to DPP-4i.

PMID 43053103
阅读全文 →
PubMedJournal of the American Chemical Society2026-11-19

An Aqueous Phase Transition Electrolyte Retaining High Ionic Conductivity after Solidification for Low-Temperature Zinc-Iodine Batteries.

Li Xixian X, Yang Qi Q, Wang Hongwei H, Xu Wenyu W et al.

Conventional low-temperature aqueous electrolytes are primarily designed to suppress electrolyte freezing and thereby preserve ion transport in the liquid state, but such strategies become ineffective once electrolyte solidification becomes unavoidable. Here, we report an aqueous phase-transition electrolyte (PTE) that preserves intimate electrode-electrolyte contact and exhibits high ionic conductivity after solidification. Systematic characterization reveals that the solidified PTE consists of an interconnected ice framework permeated by a continuous liquid electrolyte, whereas a conventional ZnSO4-based electrolyte (ZSBE) forms isolated salt domains within the ice matrix, resulting in poor interfacial contact and limited ionic transport. This unique architecture establishes continuous ion-transport pathways throughout the solidified electrolyte, enabling an ionic conductivity of 1.870 mS cm-1 at -60 °C, compared to only 0.065 mS cm-1 for ZSBE. Using an aqueous Zn||I2 battery as a model system, PTE affords exceptional cycling stability and rate capability at low temperatures, achieving a record-high cycling lifespan of 430 000 cycles at 40 A g-1 and -40 °C. An Ah-level pouch cell remains operational in liquid nitrogen, powering 107 light-emitting diodes. This work marks a paradigm shift from preventing electrolyte freezing to sustaining high ionic conductivity after solidification for low-temperature aqueous batteries.

PMID 43053386
阅读全文 →
PubMedNature communications2026-11-19

Bicontinuous Fibre Formation via Co-precipitate Attenuated Solvent Transfer Induced Assembly.

Kharal Shankar P SP, Gao Yawei Y, Bo Luyu L, Damron Joshua T JT et al.

Polymer-solvent-nonsolvent mixtures provide a versatile route for fabricating structured materials through liquid-liquid phase separation. In this context, solvent transfer-induced phase separation (STrIPS) enables the continuous formation of bicontinuous fibres, yet the process is often limited by coarsening of pores or collapse within the fibre core, leading to structural inhomogeneity. Here, we advance this strategy through Co-precipitate Attenuated Solvent Transfer induced assembly (CAST), in which amphiphilic species precipitate in situ during solvent exchange and preferentially retained within the polymer rich phase. These precipitates act as a distributed molecular retarding agent that delays domain growth, thereby preserving bicontinuity throughout the fibre cross-section to up to 250 µm. Using a poly (ethylene glycol) diacrylate-ethanol-water system with a phenolic oligomer coprecipitate, we demonstrate that CAST stabilizes the hollow bicontinuous domain structure, extending the attainable specific surface area by ca. 100%. Scattering experiments and molecular dynamics simulations confirm that the precipitating species suppress coarsening by restricting mobility within the phase they occupy. Embedding CAST fibres within polydimethylsiloxane demonstrates lightweight composites with sound mitigation capabilities, highlighting the potential for acoustic applications. CAST thus establishes a versatile route to high-performance porous materials with broad potential for structural, acoustic, and energy applications.

PMID 43052242
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多teriparatide